Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Access signs more agreements for distribution of amlexanox

Oct. 14, 1998

More data reported for ADCON-P; FDA okays pivotal trial

Oct. 14, 1998

Demegen's Peptidyl MIM compound D4B effectively treats infected wounds

Oct. 13, 1998

Xoma completes phase II enrollment in psoriasis study

Oct. 13, 1998

Bristol-Myers Squibb and Unilever enter collaborative agreement for hair loss research

Oct. 9, 1998

Nonpeptide BK antagonist effective in guinea pig models of allergy

Oct. 7, 1998

Thalomid now available for prescribing in U.S.

Oct. 2, 1998

Chrysalis begins clinical evaluation of wound-healing agent

Sep. 30, 1998

Gliatech reports promising pilot clinical trial results with ADCON-P

Sep. 29, 1998

Fujisawa concludes agreement for development of calcipotriol

Sep. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...